ERBA molecular is an IVD company with a novel, commercially validated and integrated molecular diagnostic system. ERBA Molecular' approach to simplified diagnostic workflow employs a next generation isothermal amplification technology which integrates with an innovative sample preparation technology and a patented, real-time detection technology. This combination provides a low cost, easy to use molecular solution for near-patient or decentralised testing.
ERBA's molecular diagnostic system is also ideally suited for medium volume throughput hospital laboratories and has been successfully deployed by its commercial partners in a variety of non-traditional settings. This is facilitated by ERBA Molecular having successfully combined complex molecular diagnostic technologies into a few simple steps; removing the need for highly skilled operators. Consequently this approach provides a pathway for a CLIA waivable POC system for use in such locations as physician office labs, STD clinics, blood collection sites and resource-poor settings.